March 11, 2020
Prime Therapeutics delivers single-digit pharmacy trend increases for Commercial and Medicare Part D despite increased medication use
Commercial drug trend held to 4.7% while Medicare Part D trend is nearly flat at 0.1%.
January 27, 2020
Capital BlueCross advances its precision drug access & cost reduction initiatives with new pharmacy benefit manager
Prime Therapeutics’ unique assets will help lead innovation in a revolutionary drug era.
Jan. 9, 2020
Schlett is an experienced finance executive with more than 25 years of business, leadership experience.